Top

Category: Editorial


Editorial

Man and Machine: What Comes Next as Neuralink and Synchron Start Clinical Trials

May 28, 2024

Via: Camila Mendes

The two companies leading the charge in integrating human physiology with machinery, Neuralink and Synchron, have both entered the human clinical trials stage of research and development. Both companies aim to improve and eventually restore patients’ mobility, filling the unmet […]


Editorial

How Tech is Fighting the Battle Against Counterfeit Pharmaceuticals

May 15, 2024

Via: Caitlin Simmons

The pharmaceutical world is a key foundation of modern medicine. It offers critical treatments that help millions survive globally, as well as improve their standards of living. Nevertheless, underneath all these major advantages lies an unclear issue that affects both […]


Editorial

Neuralink and Synchron: The Billionaire Battle of the Brain Chip

April 30, 2024

Via: Camila Mendes

Elon Musk. Jeff Bezos. Bill Gates. These three men have a lot in common. They’re all tech founders who have disrupted their respective industries and cemented their place in the annals of history for their global (and extra-terrestrial) dominance. Between […]


Editorial

Precision Medicine With Additive Manufacturing

March 25, 2024

Via: Mary Gamet

Additive manufacturing (AM) and 3D printing came into the tech scene as some of the most disruptive technologies, indicating that we are on the precipice of the fourth industrial revolution. These advancements have affected pharmaceutical market growth, which has expanded […]


Editorial

A Look Inside the Global Biopharmaceutical Supply Chain

February 29, 2024

Via: Caitlin Simmons

Welcome to the land of biopharmaceuticals, where the wonders of medicine meet with the intricacies of distribution networks. The biopharma sector is blazing a trail in creating life-saving medications, vaccines, and treatments. These aren’t merely commodities, they serve as support […]


Editorial

Fierce JPM Week: A Roundup of Biopharma’s Biggest Week

January 31, 2024

Via: Camila Mendes

For the biopharma industry, the start of the year holds one of the biggest events in the global industry calendar, JPM Week. It’s the ultimate meeting of minds, bringing together scientists, pharmaceutical industry professionals, bankers, investors, startup founders, journalists, and […]


Editorial

The A-Z of AstraZeneca’s Billion Dollar Acquisition

December 18, 2023

Via: Camila Mendes

With a $1.2 billion dollar acquisition of Gracell Biotechnologies, pharmaceutical giant AstraZeneca has firmly entrenched itself in the Asian market. The company is not only expanding its footprint, but also broadening its scope with its foray into cell therapy—Gracell’s specialized […]


Editorial

The FDA grants accelerated approval for Pfizer’s Elrexfio

November 28, 2023

Via: Camila Mendes

For patients living with Relapsed or Refractory Multiple Myeloma (RRMM), life revolves around treatment cycles, clinical trials, brief periods of good health, and the uncertainty of when they will be sick again. By definition, RRMM is a rare type of […]


Editorial

A Comprehensive Guide to Mobile Payment Technologies

November 9, 2023

Via: Caitlin Simmons

Mobile payment technologies have reshaped the way we handle financial transactions in today’s fast-paced, digitally connected world. These technologies have swiftly become an integral part of our daily lives, offering convenience, security, and efficiency that traditional payment methods can’t match. […]


Editorial

Personalized Medicine’s Role in Biopharma’s Future

October 30, 2023

Via: Caitlin Simmons

In an era marked by unprecedented advancements in biomedical science and technology, personalized medicine has emerged as a transformative force within the biopharmaceutical industry. This introduction sets the stage for exploring how tailor-madepersonalized medicine is reshaping the landscape of healthcare, […]


Editorial

How the Biopharma Industry Is Using Blockchain to Increase Security

September 29, 2023

Via: Rassell Neal

Biopharma supply chains have a far-reaching impact on health worldwide and should be managed accordingly.  However, complexities in the manufacturing, distribution, and delivery of life-saving drugs are unavoidable—especially given the lingering effects of the pandemic and the current global economic […]


Editorial

ESG in Biopharma: Paving the Path to Sustainability

August 31, 2023

Via: Isaac Carew

In an era characterized by heightened corporate accountability, the biopharmaceutical industry is no exception to the scrutiny surrounding Environmental, Social, and Governance (ESG) practices. In recent years, concerns about the environmental impact of biopharma operations have intensified, prompting a critical […]


Editorial

Exciting Advancements in Cancer Research and Vaccine Development

July 31, 2023

Via: Natalie Dunn

According to the Mayo Clinic, cancer is a term used to describe a wide range of diseases where abnormal cells proliferate uncontrollably, infiltrating and damaging healthy tissues. Cancer can metastasize, spreading throughout the body and affecting more and more organs. […]


Editorial

Why Vaccine Research and Development Is Important in 2023

June 20, 2023

Via: Natalie Dunn

The COVID-19 pandemic has caused significant disruptions worldwide, altering people’s lifestyles and forcing industries to adapt. Despite the fact that the healthcare crisis has ended, its impact continues to reshape various sectors globally. Businesses have recognized the importance of establishing […]


Editorial

How Biotech Companies Are Pioneering Innovation in Healthcare

May 22, 2023

Via: Natalie Dunn

Biotech companies have emerged as key players in driving innovation and transformation in the healthcare sector. Their efforts have led to the development of life-changing treatments and therapies that harness the power of technology to enhance patient care and improve […]


Editorial

Biopharma in 2023: Explore Seven Significant Trends

April 28, 2023

Via: Edgar Hoggarth

The biopharma industry is rapidly evolving and advancing in 2023. According to the Pharmaceutical Manufacturing Market Size report, its overall growth will continue at a rate of 11.34% from 2021 to 2028. However, while the industry has long been labeled […]


Editorial

Breakthroughs in the Treatment and Prevention of Cardiovascular Diseases

April 27, 2023

Via: Natalie Dunn

There is no question that cardiovascular diseases (CVDs) are a top priority for scientists and healthcare experts. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, with 17.9 million people dying every year.  The […]


Editorial

Oncology Breakthroughs Can Now Improve Patient Outcomes

February 23, 2023

Via: Natalie Dunn

There is no question that a cancer diagnosis has long inspired dread among both patients and doctors. Depending on the type and severity of the disease, cancer can be challenging to diagnose and treat, and the medical community is still […]


Editorial

5 New Treatments Could Soon Ameliorate Debilitating Illnesses

January 30, 2023

Via: Natalie Dunn

The last few years have been challenging for scientists, researchers, and doctors around the world. As the COVID-19 pandemic spread everywhere and an increasing number of people contracted the virus, the development of new vaccines, treatments, and drugs became crucial. […]


Editorial

Emerging Technologies That Will Transform the Pharmaceutical Industry

December 29, 2022

Via: Sandra Ferguson

The pharmaceutical sector is highly capital-intensive and competitive, with new technologies and innovations being developed all the time. As the industry transitions to the digital age, emerging inventions are transforming the way drugs are developed, tested, and marketed. These technologies […]